[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Age-related Macular Degeneration Market Professional Survey Report 2018

February 2018 | 112 pages | ID: G6DD9D9E9B0EN
QYResearch

US$ 3,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report studies Age-related Macular Degeneration in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2013 to 2018, and forecast to 2025.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
  • Bayer HealthCare
  • F. Hoffmann-La Roche
  • Novartis
  • Regeneron Pharmaceuticals
  • Alcon
  • Allergan
  • Avalanche
  • Bausch+Lomb
  • Gilead Sciences
  • Iconic Therapeutics
  • Neurotech Pharmaceuticals
  • Ohr Pharmaceutical
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Wet AMD
  • Dry AMD
By Application, the market can be split into
  • Drugstore
  • Hospital
  • Others
By Regions, this report covers (we can add the regions/countries as you want)
  • North America
  • China
  • Europe
  • Southeast Asia
  • Japan
  • India
If you have any special requirements, please let us know and we will offer you the report as you want.
Global Age-related Macular Degeneration Market Professional Survey Report 2018

1 INDUSTRY OVERVIEW OF AGE-RELATED MACULAR DEGENERATION

1.1 Definition and Specifications of Age-related Macular Degeneration
  1.1.1 Definition of Age-related Macular Degeneration
  1.1.2 Specifications of Age-related Macular Degeneration
1.2 Classification of Age-related Macular Degeneration
  1.2.1 Wet AMD
  1.2.2 Dry AMD
1.3 Applications of Age-related Macular Degeneration
  1.3.1 Drugstore
  1.3.2 Hospital
  1.3.3 Others
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF AGE-RELATED MACULAR DEGENERATION

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Age-related Macular Degeneration
2.3 Manufacturing Process Analysis of Age-related Macular Degeneration
2.4 Industry Chain Structure of Age-related Macular Degeneration

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF AGE-RELATED MACULAR DEGENERATION

3.1 Capacity and Commercial Production Date of Global Age-related Macular Degeneration Major Manufacturers in 2017
3.2 Manufacturing Plants Distribution of Global Age-related Macular Degeneration Major Manufacturers in 2017
3.3 R&D Status and Technology Source of Global Age-related Macular Degeneration Major Manufacturers in 2017
3.4 Raw Materials Sources Analysis of Global Age-related Macular Degeneration Major Manufacturers in 2017

4 GLOBAL AGE-RELATED MACULAR DEGENERATION OVERALL MARKET OVERVIEW

4.1 2013-2018E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2013-2018E Global Age-related Macular Degeneration Capacity and Growth Rate Analysis
  4.2.2 2017 Age-related Macular Degeneration Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2013-2018E Global Age-related Macular Degeneration Sales and Growth Rate Analysis
  4.3.2 2017 Age-related Macular Degeneration Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2013-2018E Global Age-related Macular Degeneration Sales Price
  4.4.2 2017 Age-related Macular Degeneration Sales Price Analysis (Company Segment)

5 AGE-RELATED MACULAR DEGENERATION REGIONAL MARKET ANALYSIS

5.1 North America Age-related Macular Degeneration Market Analysis
  5.1.1 North America Age-related Macular Degeneration Market Overview
  5.1.2 North America 2013-2018E Age-related Macular Degeneration Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2013-2018E Age-related Macular Degeneration Sales Price Analysis
  5.1.4 North America 2017 Age-related Macular Degeneration Market Share Analysis
5.2 China Age-related Macular Degeneration Market Analysis
  5.2.1 China Age-related Macular Degeneration Market Overview
  5.2.2 China 2013-2018E Age-related Macular Degeneration Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2013-2018E Age-related Macular Degeneration Sales Price Analysis
  5.2.4 China 2017 Age-related Macular Degeneration Market Share Analysis
5.3 Europe Age-related Macular Degeneration Market Analysis
  5.3.1 Europe Age-related Macular Degeneration Market Overview
  5.3.2 Europe 2013-2018E Age-related Macular Degeneration Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2013-2018E Age-related Macular Degeneration Sales Price Analysis
  5.3.4 Europe 2017 Age-related Macular Degeneration Market Share Analysis
5.4 Southeast Asia Age-related Macular Degeneration Market Analysis
  5.4.1 Southeast Asia Age-related Macular Degeneration Market Overview
  5.4.2 Southeast Asia 2013-2018E Age-related Macular Degeneration Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2013-2018E Age-related Macular Degeneration Sales Price Analysis
  5.4.4 Southeast Asia 2017 Age-related Macular Degeneration Market Share Analysis
5.5 Japan Age-related Macular Degeneration Market Analysis
  5.5.1 Japan Age-related Macular Degeneration Market Overview
  5.5.2 Japan 2013-2018E Age-related Macular Degeneration Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2013-2018E Age-related Macular Degeneration Sales Price Analysis
  5.5.4 Japan 2017 Age-related Macular Degeneration Market Share Analysis
5.6 India Age-related Macular Degeneration Market Analysis
  5.6.1 India Age-related Macular Degeneration Market Overview
  5.6.2 India 2013-2018E Age-related Macular Degeneration Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2013-2018E Age-related Macular Degeneration Sales Price Analysis
  5.6.4 India 2017 Age-related Macular Degeneration Market Share Analysis

6 GLOBAL 2013-2018E AGE-RELATED MACULAR DEGENERATION SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2013-2018E Age-related Macular Degeneration Sales by Type
6.2 Different Types of Age-related Macular Degeneration Product Interview Price Analysis
6.3 Different Types of Age-related Macular Degeneration Product Driving Factors Analysis
  6.3.1 Wet AMD of Age-related Macular Degeneration Growth Driving Factor Analysis
  6.3.2 Dry AMD of Age-related Macular Degeneration Growth Driving Factor Analysis

7 GLOBAL 2013-2018E AGE-RELATED MACULAR DEGENERATION SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2013-2018E Age-related Macular Degeneration Consumption by Application
7.2 Different Application of Age-related Macular Degeneration Product Interview Price Analysis
7.3 Different Application of Age-related Macular Degeneration Product Driving Factors Analysis
  7.3.1 Drugstore of Age-related Macular Degeneration Growth Driving Factor Analysis
  7.3.2 Hospital of Age-related Macular Degeneration Growth Driving Factor Analysis
  7.3.3 Others of Age-related Macular Degeneration Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF AGE-RELATED MACULAR DEGENERATION

8.1 Bayer HealthCare
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 Bayer HealthCare 2017 Age-related Macular Degeneration Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Bayer HealthCare 2017 Age-related Macular Degeneration Business Region Distribution Analysis
8.2 F. Hoffmann-La Roche
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 F. Hoffmann-La Roche 2017 Age-related Macular Degeneration Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 F. Hoffmann-La Roche 2017 Age-related Macular Degeneration Business Region Distribution Analysis
8.3 Novartis
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 Novartis 2017 Age-related Macular Degeneration Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Novartis 2017 Age-related Macular Degeneration Business Region Distribution Analysis
8.4 Regeneron Pharmaceuticals
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 Regeneron Pharmaceuticals 2017 Age-related Macular Degeneration Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Regeneron Pharmaceuticals 2017 Age-related Macular Degeneration Business Region Distribution Analysis
8.5 Alcon
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 Alcon 2017 Age-related Macular Degeneration Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Alcon 2017 Age-related Macular Degeneration Business Region Distribution Analysis
8.6 Allergan
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 Allergan 2017 Age-related Macular Degeneration Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Allergan 2017 Age-related Macular Degeneration Business Region Distribution Analysis
8.7 Avalanche
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Product A
    8.7.2.2 Product B
  8.7.3 Avalanche 2017 Age-related Macular Degeneration Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Avalanche 2017 Age-related Macular Degeneration Business Region Distribution Analysis
8.8 Bausch+Lomb
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Product A
    8.8.2.2 Product B
  8.8.3 Bausch+Lomb 2017 Age-related Macular Degeneration Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Bausch+Lomb 2017 Age-related Macular Degeneration Business Region Distribution Analysis
8.9 Gilead Sciences
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
    8.9.2.1 Product A
    8.9.2.2 Product B
  8.9.3 Gilead Sciences 2017 Age-related Macular Degeneration Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 Gilead Sciences 2017 Age-related Macular Degeneration Business Region Distribution Analysis
8.10 Iconic Therapeutics
  8.10.1 Company Profile
  8.10.2 Product Picture and Specifications
    8.10.2.1 Product A
    8.10.2.2 Product B
  8.10.3 Iconic Therapeutics 2017 Age-related Macular Degeneration Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.10.4 Iconic Therapeutics 2017 Age-related Macular Degeneration Business Region Distribution Analysis
8.11 Neurotech Pharmaceuticals
8.12 Ohr Pharmaceutical

9 DEVELOPMENT TREND OF ANALYSIS OF AGE-RELATED MACULAR DEGENERATION MARKET

9.1 Global Age-related Macular Degeneration Market Trend Analysis
  9.1.1 Global 2018-2025 Age-related Macular Degeneration Market Size (Volume and Value) Forecast
  9.1.2 Global 2018-2025 Age-related Macular Degeneration Sales Price Forecast
9.2 Age-related Macular Degeneration Regional Market Trend
  9.2.1 North America 2018-2025 Age-related Macular Degeneration Consumption Forecast
  9.2.2 China 2018-2025 Age-related Macular Degeneration Consumption Forecast
  9.2.3 Europe 2018-2025 Age-related Macular Degeneration Consumption Forecast
  9.2.4 Southeast Asia 2018-2025 Age-related Macular Degeneration Consumption Forecast
  9.2.5 Japan 2018-2025 Age-related Macular Degeneration Consumption Forecast
  9.2.6 India 2018-2025 Age-related Macular Degeneration Consumption Forecast
9.3 Age-related Macular Degeneration Market Trend (Product Type)
9.4 Age-related Macular Degeneration Market Trend (Application)

10 AGE-RELATED MACULAR DEGENERATION MARKETING TYPE ANALYSIS

10.1 Age-related Macular Degeneration Regional Marketing Type Analysis
10.2 Age-related Macular Degeneration International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Age-related Macular Degeneration by Region
10.4 Age-related Macular Degeneration Supply Chain Analysis

11 CONSUMERS ANALYSIS OF AGE-RELATED MACULAR DEGENERATION

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL AGE-RELATED MACULAR DEGENERATION MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Picture of Age-related Macular Degeneration
Table Product Specifications of Age-related Macular Degeneration
Table Classification of Age-related Macular Degeneration
Figure Global Production Market Share of Age-related Macular Degeneration by Type in 2017
Figure Wet AMD Picture
Table Major Manufacturers of Wet AMD
Figure Dry AMD Picture
Table Major Manufacturers of Dry AMD
Table Applications of Age-related Macular Degeneration
Figure Global Consumption Volume Market Share of Age-related Macular Degeneration by Application in 2017
Figure Drugstore Examples
Table Major Consumers in Drugstore
Figure Hospital Examples
Table Major Consumers in Hospital
Figure Others Examples
Table Major Consumers in Others
Figure Market Share of Age-related Macular Degeneration by Regions
Figure North America Age-related Macular Degeneration Market Size (Million USD) (2013-2025)
Figure China Age-related Macular Degeneration Market Size (Million USD) (2013-2025)
Figure Europe Age-related Macular Degeneration Market Size (Million USD) (2013-2025)
Figure Southeast Asia Age-related Macular Degeneration Market Size (Million USD) (2013-2025)
Figure Japan Age-related Macular Degeneration Market Size (Million USD) (2013-2025)
Figure India Age-related Macular Degeneration Market Size (Million USD) (2013-2025)
Table Age-related Macular Degeneration Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Age-related Macular Degeneration in 2017
Figure Manufacturing Process Analysis of Age-related Macular Degeneration
Figure Industry Chain Structure of Age-related Macular Degeneration
Table Capacity and Commercial Production Date of Global Age-related Macular Degeneration Major Manufacturers in 2017
Table Manufacturing Plants Distribution of Global Age-related Macular Degeneration Major Manufacturers in 2017
Table R&D Status and Technology Source of Global Age-related Macular Degeneration Major Manufacturers in 2017
Table Raw Materials Sources Analysis of Global Age-related Macular Degeneration Major Manufacturers in 2017
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of Age-related Macular Degeneration 2013-2018E
Figure Global 2013-2018E Age-related Macular Degeneration Market Size (Volume) and Growth Rate
Figure Global 2013-2018E Age-related Macular Degeneration Market Size (Value) and Growth Rate
Table 2013-2018E Global Age-related Macular Degeneration Capacity and Growth Rate
Table 2017 Global Age-related Macular Degeneration Capacity (K Units) List (Company Segment)
Table 2013-2018E Global Age-related Macular Degeneration Sales (K Units) and Growth Rate
Table 2017 Global Age-related Macular Degeneration Sales (K Units) List (Company Segment)
Table 2013-2018E Global Age-related Macular Degeneration Sales Price (USD/Unit)
Table 2017 Global Age-related Macular Degeneration Sales Price (USD/Unit) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Units) of Age-related Macular Degeneration 2013-2018E
Figure North America 2013-2018E Age-related Macular Degeneration Sales Price (USD/Unit)
Figure North America 2017 Age-related Macular Degeneration Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Units) of Age-related Macular Degeneration 2013-2018E
Figure China 2013-2018E Age-related Macular Degeneration Sales Price (USD/Unit)
Figure China 2017 Age-related Macular Degeneration Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Units) of Age-related Macular Degeneration 2013-2018E
Figure Europe 2013-2018E Age-related Macular Degeneration Sales Price (USD/Unit)
Figure Europe 2017 Age-related Macular Degeneration Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Units) of Age-related Macular Degeneration 2013-2018E
Figure Southeast Asia 2013-2018E Age-related Macular Degeneration Sales Price (USD/Unit)
Figure Southeast Asia 2017 Age-related Macular Degeneration Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Units) of Age-related Macular Degeneration 2013-2018E
Figure Japan 2013-2018E Age-related Macular Degeneration Sales Price (USD/Unit)
Figure Japan 2017 Age-related Macular Degeneration Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Units) of Age-related Macular Degeneration 2013-2018E
Figure India 2013-2018E Age-related Macular Degeneration Sales Price (USD/Unit)
Figure India 2017 Age-related Macular Degeneration Sales Market Share
Table Global 2013-2018E Age-related Macular Degeneration Sales (K Units) by Type
Table Different Types Age-related Macular Degeneration Product Interview Price
Table Global 2013-2018E Age-related Macular Degeneration Sales (K Units) by Application
Table Different Application Age-related Macular Degeneration Product Interview Price
Table Bayer HealthCare Information List
Table Product A Overview
Table Product B Overview
Table 2017 Bayer HealthCare Age-related Macular Degeneration Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Bayer HealthCare Age-related Macular Degeneration Business Region Distribution
Table F. Hoffmann-La Roche Information List
Table Product A Overview
Table Product B Overview
Table 2017 F. Hoffmann-La Roche Age-related Macular Degeneration Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 F. Hoffmann-La Roche Age-related Macular Degeneration Business Region Distribution
Table Novartis Information List
Table Product A Overview
Table Product B Overview
Table 2015 Novartis Age-related Macular Degeneration Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Novartis Age-related Macular Degeneration Business Region Distribution
Table Regeneron Pharmaceuticals Information List
Table Product A Overview
Table Product B Overview
Table 2017 Regeneron Pharmaceuticals Age-related Macular Degeneration Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Regeneron Pharmaceuticals Age-related Macular Degeneration Business Region Distribution
Table Alcon Information List
Table Product A Overview
Table Product B Overview
Table 2017 Alcon Age-related Macular Degeneration Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Alcon Age-related Macular Degeneration Business Region Distribution
Table Allergan Information List
Table Product A Overview
Table Product B Overview
Table 2017 Allergan Age-related Macular Degeneration Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Allergan Age-related Macular Degeneration Business Region Distribution
Table Avalanche Information List
Table Product A Overview
Table Product B Overview
Table 2017 Avalanche Age-related Macular Degeneration Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Avalanche Age-related Macular Degeneration Business Region Distribution
Table Bausch+Lomb Information List
Table Product A Overview
Table Product B Overview
Table 2017 Bausch+Lomb Age-related Macular Degeneration Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Bausch+Lomb Age-related Macular Degeneration Business Region Distribution
Table Gilead Sciences Information List
Table Product A Overview
Table Product B Overview
Table 2017 Gilead Sciences Age-related Macular Degeneration Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Gilead Sciences Age-related Macular Degeneration Business Region Distribution
Table Iconic Therapeutics Information List
Table Product A Overview
Table Product B Overview
Table 2017 Iconic Therapeutics Age-related Macular Degeneration Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2017 Iconic Therapeutics Age-related Macular Degeneration Business Region Distribution
Table Neurotech Pharmaceuticals Information List
Table Ohr Pharmaceutical Information List
Figure Global 2018-2025 Age-related Macular Degeneration Market Size (K Units) and Growth Rate Forecast
Figure Global 2018-2025 Age-related Macular Degeneration Market Size (Million USD) and Growth Rate Forecast
Figure Global 2018-2025 Age-related Macular Degeneration Sales Price (USD/Unit) Forecast
Figure North America 2018-2025 Age-related Macular Degeneration Consumption Volume (K Units) and Growth Rate Forecast
Figure China 2018-2025 Age-related Macular Degeneration Consumption Volume (K Units) and Growth Rate Forecast
Figure Europe 2018-2025 Age-related Macular Degeneration Consumption Volume (K Units) and Growth Rate Forecast
Figure Southeast Asia 2018-2025 Age-related Macular Degeneration Consumption Volume (K Units) and Growth Rate Forecast
Figure Japan 2018-2025 Age-related Macular Degeneration Consumption Volume (K Units) and Growth Rate Forecast
Figure India 2018-2025 Age-related Macular Degeneration Consumption Volume (K Units) and Growth Rate Forecast
Table Global Sales Volume (K Units) of Age-related Macular Degeneration by Type 2018-2025
Table Global Consumption Volume (K Units) of Age-related Macular Degeneration by Application 2018-2025
Table Traders or Distributors with Contact Information of Age-related Macular Degeneration by Region


More Publications